60296 Federal Register / Vol. 73, No. 198 / Friday, October 10, 2008 / Notices 

Dated: October 1, 2008. 

Antonia T. Harris, 

Deputy Assistant Secretary for Human 

Resources,Department of Health and Human 

Services. 

[FR Doc. E8–23796 Filed 10–9–08; 8:45 am] 

BILLING CODE 5150–04–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: Occupational Safety 

and Health Training Projects Grants, 

Request for Applications (RFA) 06– 

484; Occupational Safety and Health 

Educational Research Centers, RFA 

06–485 

In accordance with section 10(a)(2) of 

the Federal AdvisoryCommittee Act 

(Pub. L. 92–463), the Centers for 

DiseaseControl and Prevention (CDC) 

announces the aforementioned meeting: 

Times and Dates:8:30 a.m.–5 p.m., 

December 11, 2008 (Closed).8:30 a.m.–5 

p.m., December 12, 2008 (Closed). 

Place: Harbour View Inn, 2 Vendue 

Range, Charleston, South Carolina 

29401, Telephone (843) 853–8439. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in section 552b(c)(4) 

and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters To Be Discussed: The meeting 

will include the review, discussion, and 

evaluation of ‘‘Occupational Safety and 

Health Training Projects Grants, RFA 

06–484; Occupational Safety and Health 

Educational Research Centers, RFA 06– 

485.’’ 

There will be a site visit at the 

University of California, Los Angeles 

(UCLA), on November 11–13, 2008; to 

advise and make recommendations to 

the Disease, Disability, and Injury 

Prevention and Control SEP: 

Occupational Safety and Health 

Training Projects Grants, RFA 06–484; 

Occupational Safety and Health 

Educational Research Centers, RFA 06– 

485. 

Times, Dates, and Place of site visit: 

Times and Dates:7 a.m.–9 p.m., 

November 11, 2008.8 a.m.–6:30 p.m., 

November 12, 2008.8 a.m.–5 p.m., 

November 13, 2008. 

Place: UCLA Guest House, 330 

Charles E. Young Drive East, Los 

Angeles, California 90095. 

Contact Person for More Information: 

Dr. M. Chris Langub, Ph.D., Scientific 

Review Administrator, 1600 Clifton 

Road NE., Mailstop E74, Atlanta, GA 

30333, telephone (404) 498–2543. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: October 1, 2008. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E8–23809 Filed 10–9–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–R–262, CMS– 

10142, CMS–10175 and CMS–R–218] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

Agency: Centers for Medicare & 

Medicaid Services. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS) is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: CY 2010 Plan 

Benefit Package (PBP) and Formulary 

Submission for Medicare Advantage 

(MA) Plans and Prescription Drug Plans 

(PDP) Use: Under the Medicare 

Modernization Act (MMA), Medicare 

Advantage (MA) and Prescription Drug 

Plan (PDP) organizations are required to 

submit plan benefit packages for all 

Medicare beneficiaries residing in their 

service area. The plan benefit package 

submission consists of the formulary 

file, Plan Benefit Package (PBP) 

software, and supporting documentation 

as necessary. MA and PDP organizations 

will generate a formulary to illustrate 

their list of drugs, including information 

on prior authorization, step therapy, 

tiering, and quantity limits. 

Additionally, the PBP software will be 

used to describe their organization’s 

plan benefit packages, including 

information on premiums, cost sharing, 

authorization rules, and supplemental 

benefits. CMS uses the formulary and 

PBP data to review and approve the 

plan benefit packages proposed by each 

MA and PDP organization. 

CMS requires that MA and PDP 

organizations submit a completed 

formulary and PBP as part of the annual 

bidding process. During this process, 

organizations prepare their proposed 

plan benefit packages for the upcoming 

contract year and submit them to CMS 

for review and approval. Based on 

operational changes and policy 

clarifications to the Medicare program 

and continued input and feedback by 

the industry, CMS has made the 

necessary changes to the plan benefit 

package submission. Form Number: 

CMS–R–262 (OMB# 0938–0763); 

Frequency: Yearly; Affected Public: 

Business or other for-profits b. Not-forprofit institutions; Number of 

Respondents: 475; Total Annual 

Responses: 4987.5; Total Annual Hours: 

12112.5. 

2. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: CY 2010 Bid 

Pricing Tool (BPT) for Medicare 

Advantage (MA) Plans and Prescription 

Drug Plans (PDP). Use: Under the 

Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003 (MMA), and implementing 

regulations at 42 CFR, Medicare 

Advantage organizations (MAO) and 

Prescription Drug Plans (PDP) are 

required to submit an actuarial pricing 

‘‘bid’’ for each plan offered to Medicare 

beneficiaries for approval by CMS. 

MAOs and PDPs use the Bid Pricing 

Tool (BPT) software to develop their 

actuarial pricing bid. The information 

provided in the BPT is the basis for the 

plan’s enrollee premiums and CMS 

payments for each contract year. The 

tool collects data such as medical 

expense development (from claims data 

and/or manual rating), administrative 

expenses, profit levels, and projected 

plan enrollment information. By statute, 

mstockstill on PROD1PC66 with NOTICES